DUSA Pharmaceuticals, a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. has received relief from a U.S. court in a patent infringement case. According to...
SEBI has announced that it is examining the whistleblower complaint against Dilip Shanghvi, CEO and Managing Director of Sun Pharmaceutical Industries. SEBI Chairman Ajay Tyagi...